Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	at least one local adverse event	27819	27953	Eleven of 17 (65%) women who received Acidform had at least 1 AE compared with 2 of 18 (11%) who received HEC placebo gel (p = 0.002).
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	at least one local adverse event	1290	1422	However, 65% of women who received Acidform had at least one local adverse event compared with 11% who received placebo (p = 0.002).
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	The median vaginal and cervical pH	1104	1289	The median vaginal and cervical pH was significantly lower 2 hours after application of Acidform and was associated with an increase in the bactericidal activity of CVL against E. coli.
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	G. vaginalis	1689	1875	There were no significant changes in Lactobacillus crispatus or Lactobacillus jensenii in either group but there was a decrease in Gardnerella vaginalis in the Acidform group (p = 0.08).
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	The median vaginal and cervical pH	28310	28486	The median pH at the cervix, lateral vaginal wall, posterior fornix and CVL was significantly lower 2 hours after application of Acidform compared to the placebo group (p<0.01)
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	CVL concentrations of lactoferrin and interleukin-1 receptor antagonist (IL-1ra), an anti-inflammatory protein,	1423	1688	While there was no increase in inflammatory cytokines or chemokines, CVL concentrations of lactoferrin and interleukin-1 receptor antagonist (IL-1ra), an anti-inflammatory protein, were significantly lower following Acidform compared to HEC placebo gel application.
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	detectable L. crispatus or L. jensenii	31973	32208	There were no significant changes in the number of women with detectable L. crispatus or L. jensenii or in the concentrations of bacteria recovered by PCR in the Acidform or HEC group following 14 days of twice daily gel use (Table 4).
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	detectable L. crispatus or L. jensenii	1689	1791	There were no significant changes in Lactobacillus crispatus or Lactobacillus jensenii in either group
Acidform twice daily for 14 consecutive days	hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days	G. vaginalis	32209	32399	However, there was a trend towards a decrease in the concentration of G. vaginalis following repeated application of Acidform from a median of 1.3×106 to 3.6×104 DNA copies/swab (p = 0.083).
